Pain Management News

Guidelines for cannabis and prescription opioid use in the management of cancer-associated pain should reflect changing patient attitudes toward these approaches, according to study findings.

Individuals with narcolepsy were significantly more likely to have sleep, mood and pain disorders compared with matched controls, indicating where treatment may best target common comorbidities, according to new research from Sleep Advances.

Primary care providers can use self-assessments and other resources to diagnose medically unexplained chronic symptoms and offer relief for patients, according to an expert.

Medical marijuana use led to improvements in health-related quality of life among adults referred for medical marijuana by a physician to treat qualifying medical conditions, according to a study published in Journal of Cannabis Research.

Aug. 31 is International Overdose Awareness Day. It is a time to remember those lost to substance use disorders and addiction, particularly as the United States and countries around the globe grapple with the opioid crisis.

There are two FDA-approved medications for PTSD, both selective serotonin reuptake inhibitors. The FDA has not approved a new medication for PTSD since 2001.

The FDA on Aug. 9 issued a complete response letter to Lycos Therapeutics for its new drug application regarding midomafetamine capsules for the treatment of PTSD, citing insufficient data to approve and requesting an additional phase 3 trial.

Patients with breast cancer who reported high burdens of pain and stress had poorer outcomes than those with lower pain or stress levels, according to research presented at ASCO Annual Meeting.

Acupuncture was superior to sham acupuncture in reducing methadone doses and opioid cravings in patients undergoing treatment for opioid addiction, findings showed.